A cohort of 250 patients diagnosed with stage II or III CRC in 2004 and alive 42 months after diagnosis was identified from health administrative data in Manitoba, Canada. Colonoscopy, liver imaging, ...
At this age, the risk of heart disease, diabetes, cancer, and thyroid problems increases. Therefore, both men and women ...
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. The latest market report published by Credence Research, Inc. “Global Carcinoembryonic Antigen (CEA) Market - ...
Trends in surveillance testing after treatment for colorectal cancer remained relatively stable recently, and patients who overutilized surveillance measures had quicker recurrence detection but ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health Inc. (Nasdaq: GH), a leading precision oncology company, announced today that Guardant Reveal™, the only tissue-free test for the detection of ...